ACON: Rega marang dodolan Aclarion Inc

Simbol lan logo merek Aclarion Inc (ACON)

Risks of slow software adoption by surgeons and liquidity shortages are constraining the growth of Aclarion (ACON), as clearly demonstrated by the company's flattened P/S ratio. The current level of this metric is 46.20. Meanwhile, AI solutions for MRI scan analysis are providing a technological breakthrough in pain diagnostics. Stable demand for spinal treatment makes the business resilient to economic crises.

ACON (Aclarion, Inc.) riwayat Multiplikator P/S saka 28.04.2023 nganti 13.11.2026

Rincian analitis perusahaan Aclarion Corp (ACON)

- rega pasar lan target rega analis:
Kutipan saham aclarion.com|ACON - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Nilai pasar Aclarion Corp|ACON - Nilai Perusahaan
- data nilai buku modal saham:
Ekuitas saben Saham Aclarion|ACON - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku aclarion.com|ACON - Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Aclarion|ACON - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Aclarion Corporation|ACON - Utang perusahaan|Rasio utang marang kapitalisasi buku Aclarion Corp|ACON - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Aclarion|Likuiditas darurat aclarion.com
- indikator pendapatan resik lan kelipatan nilai:
ACON - Bathi resik perusahaan|Proyeksi bathi resik Aclarion|ACON - Koefisien rega marang bathi|Pangali Forward P/E Aclarion Inc|ACON - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Aclarion Corp|ACON - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Aclarion|ACON - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan aclarion.com|ACON - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Aclarion
- rincian pendapatan lan dodolan emiten:
ACON - Pendapatan perusahaan|Prakiraan pendapatan perusahaan aclarion.com|ACON - Kapitalisasi marang pendapatan|Rasio rega marang pendapatan sing dikarepake Aclarion Corp
Analisis fundamental perusahaan:aclarion.com ACON
Produk asli Aclarion Corp

The P/S multiple determines the market value of a business relative to its generated sales volume, helping investors assess whether an asset is overpriced or if there is a "value trap" risk when quotes are excessively undervalued. By analyzing the price-to-sales trend, one can correlate market expectations with the efficiency of the cloud distribution of the Aclarion (ACON) biomarker platform, which minimizes operating expenses by eliminating physical logistics.

Karo sapa Aclarion saingan

Kapitalisasi marang pendapatan abbott.com ABT|Multiplikator P/S TMO (Thermo Fisher)|GE HealthCare Technologies Inc. (GEHC) - Rega marang dodolan|Mettler-Toledo International Inc. - Multiplikator P/S|WAT (Waters Technologies) - Rasio kapitalisasi marang pendapatan|TECH: Multiplikator P/S|BRKR - Koefisien rega marang pendapatan|AZTA (Azenta) - Multiplikator P/S|Kapitalisasi marang pendapatan Varex Imaging Corp (VREX)|Multiplikator P/S SMLR|Multiplikator P/S Butterfly Corp (BFLY)|Rasio rega marang pendapatan Mesa Laboratories, Inc. MLAB|quantum-si.com - Rasio rega marang pendapatan|NNOX: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan QTRX (Quanterix Corp.)|MASS: Multiplikator P/S|Rega marang dodolan CapsoVision (CV)|Rasio rega marang pendapatan MaxCyte, Inc.|RPID - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan SEER (Seer)|Multiplikator P/S Hyperfine Inc (HYPR)|Multiplikator P/S FONR (FONAR Corp)|Koefisien rega marang pendapatan Daxor Corp (DXR)|MDAI - Rasio rega marang pendapatan|Rasio rega marang dodolan VIVS|akoyabio.com (AKYA) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan ThermoGenesis Holdings, Inc.|TLIS (Talis Biomedical Corp.) - Multiplikator P/S|Rega marang dodolan T2 Biosystems Inc TTOO